THYMIC CARCINOMA
Clinical trials for THYMIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new THYMIC CARCINOMA trials appear
Sign up with your email to follow new studies for THYMIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising combo targets rare thymus cancers before surgery
Disease control OngoingThis study tested whether adding the targeted drug cetuximab to standard chemotherapy could shrink advanced thymoma or thymic carcinoma tumors before surgery. 18 adults with stage II to IVA disease received the combination, then had surgery to remove any remaining tumor. Research…
Matched conditions: THYMIC CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 10:32 UTC
-
New combo therapy shows promise for rare thymic cancer
Disease control OngoingThis phase II trial tested a combination of two drugs, pembrolizumab and sunitinib, in 9 people with advanced thymic carcinoma that had spread or couldn't be removed and no longer responded to standard chemotherapy. The goal was to see if the combination could shrink tumors or st…
Matched conditions: THYMIC CARCINOMA
Phase: PHASE2 • Sponsor: Dwight Owen • Aim: Disease control
Last updated May 26, 2026 10:27 UTC
-
Immune drug avelumab shows promise for rare thymus cancers
Disease control OngoingThis study tests whether avelumab, an immunotherapy drug, is safe and can shrink tumors in people with thymoma or thymic carcinoma that came back after platinum chemotherapy. About 56 adults will receive avelumab infusions every two weeks. The goal is to see if the drug helps con…
Matched conditions: THYMIC CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Immunotherapy shows promise for rare chest cancers
Disease control OngoingThis study tests the drug nivolumab in 55 people with advanced thymoma or thymic carcinoma that has worsened after initial chemotherapy. The goal is to see if nivolumab can slow cancer growth and how safe it is. Participants receive nivolumab infusions, and researchers track tumo…
Matched conditions: THYMIC CARCINOMA
Phase: PHASE2 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated May 18, 2026 12:13 UTC
-
Chest cancer study seeks clues in blood and tissue
Knowledge-focused ENROLLING_BY_INVITATIONThis research study aims to learn more about how chest cancers like lung cancer, thymus cancer, and mesothelioma develop and spread. Researchers will collect blood, tumor tissue, and other fluids from 1,000 adult participants to look for biological markers. The goal is to find cl…
Matched conditions: THYMIC CARCINOMA
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated May 26, 2026 10:31 UTC